Nutrition rehabilitation-related complications in primary mitochondrial disorders.

Primary mitochondrial disorders (PMDs) comprise a group of hundreds of individual genetic diseases affecting mitochondrial function, including oxidative phosphorylation and energy production. The estimated prevalence of these disorders ranges from 2.9 to 20 cases per 100,000. PMDs are commonly associated with malnutrition and growth failure. There is a paucity of literature regarding nutrition assessment and long-term data in the PMD population. We present three patients with various PMDs who presented complications related to malnutrition: (1) a 16-year-old male with Kearns-Sayre syndrome developed type 2 insulin-requiring diabetes mellitus after the initiation of high-calorie nutrition rehabilitation via gastrostomy tube (G-tube); (2) an 11-year-old female with myoclonic epilepsy associated with ragged red fibers developed diarrhea with metabolic decompensation and profound neurological and respiratory deterioration during nutrition rehabilitation after surgical G-tube placement; and (3) a 19-year-old male with a WARS2-associated PMD manifesting with developmental delay and severe parkinsonism presented complications related to poor wound healing after gastrojejunostomy tube placement. The last patient required prolonged hospitalization in the intensive care unit. Clinicians should be vigilant in monitoring these possible complications, as no standards of care exist for the initiation of enteral nutrition for this unique population.

[1]  G. Sacks,et al.  ASPEN Consensus Recommendations for Refeeding Syndrome. , 2020, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[2]  Marni J. Falk,et al.  Mitochondrial disease patient motivations and barriers to participate in clinical trials , 2018, PloS one.

[3]  Young-Mock Lee,et al.  Enteral Tube Feeding in Paediatric Mitochondrial Diseases , 2017, Scientific Reports.

[4]  Marni J. Falk,et al.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2017, Genetics in Medicine.

[5]  Robert W. Taylor,et al.  Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease , 2015, Annals of neurology.

[6]  Marni J. Falk,et al.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society , 2014, Genetics in Medicine.

[7]  A. Amiot,et al.  Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. , 2009, Gastroenterology.

[8]  M. Morimoto,et al.  Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy , 2008, Brain and Development.

[9]  D. Thorburn,et al.  Minimum birth prevalence of mitochondrial respiratory chain disorders in children. , 2003, Brain : a journal of neurology.

[10]  A. Schapira,et al.  Mitochondrial disorders: an overview. , 1997, Journal of bioenergetics and biomembranes.

[11]  S. Travis,et al.  Unexplained gastrointestinal symptoms: think mitochondrial disease. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.